A new day has dawned in the fight against the U.S. opioid epidemic after the FDA approved the first over-the-counter naloxone product. And the gold medal goes to Emergent BioSolutions. Wednesday, the ...
Emergent BioSolutions was awarded a 5-year, $235.8 million contract with the U.S. Department of Defense to supply the anthrax vaccine BioThrax to the various branches of the military. Under the terms ...
Inspection reports obtained by ABC News show a series of quality control issues. Even as shots of the Johnson & Johnson COVID-19 vaccine resume across the country following a recent ...
Millions of doses were lost due to quality-control issues, the probe found. Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million ...
When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson & Johnson’s COVID-19 vaccine and millions more doses of AstraZeneca’s vaccine at its Baltimore ...
Emergent BioSolutions faces declining revenues, increasing competition, and limited growth potential, leading to a sell rating due to poor risk-reward profile. NARCAN, their main revenue generator, is ...
Emergent hits $15 million in ARR in 90 days, becomes one of the fastest growing AI start-ups; its platform is the world's first agentic vibe-coding platform that builds production-ready applications ...
Emergent co-founders and brothers Mukund Jha and Madhav Jha BENGALURU: Agentic app-building platform Emergent has raised $23 million in a Series A round led by Lightspeed India, with participation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback